Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans E Johnsen

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 17, 2004
BAC end sequencingTim S Poulsen, Hans E Johnsen
Scandinavian Cardiovascular Journal : SCJ|May 15, 2003
The clinical impact of vascular growth factors and endothelial progenitor cells in the acute coronary syndromeWang Yongzhong, Hans E Johnsen, Erik Jørgensen, et al.
British Journal of Haematology|March 10, 2005
Serum levels of inflammatory cytokines at diagnosis correlate to the bcl-6 and CD10 defined germinal centre (GC) phenotype and bcl-2 expression in patients with diffuse large B-cell lymphomaLars M Pedersen, Gitte W Jürgensen, Hans E Johnsen
Leukemia & Lymphoma|September 14, 2004
Expression of HOXA genes in patients with multiple myelomaHeidi Rye Hudlebusch, Marianne Lodahl, Hans E Johnsen, et al.
Ugeskrift for Laeger|May 7, 2010
[The clinical research unit]Hans E Johnsen, June Korup, Lene Lundby, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 17, 2003
Clinical application of dendritic cells in cancer vaccination therapyInge Marie Svane, Mette Line Soot, Søren Buus, et al.
Acta Haematologica|June 5, 2004
Molecular and clinical follow-up after treatment of multiple myelomaThomas Rasmussen, Lene M Knudsen, Tuan K Huynh, et al.
Leukemia & Lymphoma|March 22, 2016
Blood on the tracks - toward precision medicineHans E Johnsen, Tarec C El-Galaly, Karen Dybkær, et al.
Blood|September 2, 2004
Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumorsThomas Rasmussen, Michael Kuehl, Marianne Lodahl, et al.
European Journal of Haematology|May 21, 2003
Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-studyBo Björkstrand, Thomas Rasmussen, Kari Remes, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|March 17, 2004
BAC end sequencingTim S Poulsen, Hans E Johnsen
Scandinavian Cardiovascular Journal : SCJ|May 15, 2003
The clinical impact of vascular growth factors and endothelial progenitor cells in the acute coronary syndromeWang Yongzhong, Hans E Johnsen, Erik Jørgensen, et al.
British Journal of Haematology|March 10, 2005
Serum levels of inflammatory cytokines at diagnosis correlate to the bcl-6 and CD10 defined germinal centre (GC) phenotype and bcl-2 expression in patients with diffuse large B-cell lymphomaLars M Pedersen, Gitte W Jürgensen, Hans E Johnsen
Leukemia & Lymphoma|September 14, 2004
Expression of HOXA genes in patients with multiple myelomaHeidi Rye Hudlebusch, Marianne Lodahl, Hans E Johnsen, et al.
Ugeskrift for Laeger|May 7, 2010
[The clinical research unit]Hans E Johnsen, June Korup, Lene Lundby, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 17, 2003
Clinical application of dendritic cells in cancer vaccination therapyInge Marie Svane, Mette Line Soot, Søren Buus, et al.
Acta Haematologica|June 5, 2004
Molecular and clinical follow-up after treatment of multiple myelomaThomas Rasmussen, Lene M Knudsen, Tuan K Huynh, et al.
Leukemia & Lymphoma|March 22, 2016
Blood on the tracks - toward precision medicineHans E Johnsen, Tarec C El-Galaly, Karen Dybkær, et al.
Blood|September 2, 2004
Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumorsThomas Rasmussen, Michael Kuehl, Marianne Lodahl, et al.
European Journal of Haematology|May 21, 2003
Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-studyBo Björkstrand, Thomas Rasmussen, Kari Remes, et al.
Pageof 7